Royce & Associates LP Buys 167,235 Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS)

Royce & Associates LP grew its stake in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) by 157.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 273,671 shares of the semiconductor company’s stock after purchasing an additional 167,235 shares during the period. Royce & Associates LP owned approximately 0.84% of Axcelis Technologies worth $28,694,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of ACLS. Signaturefd LLC boosted its stake in shares of Axcelis Technologies by 348.9% during the 2nd quarter. Signaturefd LLC now owns 211 shares of the semiconductor company’s stock valued at $30,000 after purchasing an additional 164 shares in the last quarter. Blue Trust Inc. boosted its stake in Axcelis Technologies by 223.8% during the second quarter. Blue Trust Inc. now owns 272 shares of the semiconductor company’s stock worth $39,000 after acquiring an additional 188 shares in the last quarter. Ashton Thomas Private Wealth LLC bought a new stake in Axcelis Technologies during the second quarter worth about $39,000. Isthmus Partners LLC boosted its stake in Axcelis Technologies by 87.3% during the second quarter. Isthmus Partners LLC now owns 33,270 shares of the semiconductor company’s stock worth $47,000 after acquiring an additional 15,507 shares in the last quarter. Finally, Meeder Asset Management Inc. bought a new stake in Axcelis Technologies during the second quarter worth about $69,000. Institutional investors own 89.98% of the company’s stock.

Axcelis Technologies Stock Down 7.1 %

ACLS opened at $73.22 on Friday. The company has a quick ratio of 3.29, a current ratio of 4.45 and a debt-to-equity ratio of 0.04. The firm has a 50 day moving average price of $95.22 and a 200-day moving average price of $112.64. Axcelis Technologies, Inc. has a twelve month low of $73.15 and a twelve month high of $158.61. The stock has a market capitalization of $2.38 billion, a price-to-earnings ratio of 10.83, a PEG ratio of 2.46 and a beta of 1.60.

Analysts Set New Price Targets

ACLS has been the topic of several research reports. Benchmark lowered shares of Axcelis Technologies from a “buy” rating to a “hold” rating in a research note on Friday, November 8th. Needham & Company LLC reissued a “hold” rating on shares of Axcelis Technologies in a research note on Friday, November 8th. Finally, B. Riley dropped their target price on shares of Axcelis Technologies from $190.00 to $165.00 and set a “buy” rating on the stock in a research note on Friday, August 2nd. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $167.33.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.